Elysium Health
PrivateLast Round
Series C
Dec 23, 2019
Est. Valuation
$157M
Total Funding Raised
$80M
Company Overview
Elysium Health is a life sciences company that develops and sells clinically validated health products and supplements based on scientific research in aging.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, D2C Brands, Subscription Commerce, Clinical Trials
Business Model
B2C
Customer Profile
Subscription SaaS, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elysium Health Comparables
Compare Elysium Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Qualia Life Sciences | 86% | |
| Niagen Bioscience, Inc. | 85% | |
| NOVOS | 83% |
Elysium Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Dec 23, 2019 | ||||
| Debt | Jun 29, 2017 | ||||
| Series B | Dec 6, 2016 | ||||
| Seed | Feb 1, 2014 |
Elysium Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GISEV | Series C |
| Breyer Capital | Series C, Series B |
| Greylock Partners | Series A |
| Morningside Ventures | Series A, Series C, Series B |
| General Catalyst | Series C, Series B |
| Mayo Clinic Ventures | Series C |
| Sound Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 14, 2025
Launched COFACTOR, a 4-in-1 collagen and NAD+ system.
- Dec 23, 2019
Raised $40M led by GISEV.
Elysium Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Elysium Health's valuation, stock price, and market status.
Is Elysium Health a public or private company?
Elysium Health is a private company.
What is the current stock price of Elysium Health?
Elysium Health is a private company, so its shares have no public market price. Caplight tracks Elysium Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Elysium Health worth (valuation)?
Elysium Health's valuation is estimated at $157.0M based on funding round data.
Can I buy Elysium Health stock?
Elysium Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Elysium Health's last funding round?
Elysium Health's most recent funding round was Series C on December 23, 2019.
Who are the main investors in Elysium Health?
Key investors in Elysium Health include GISEV, General Catalyst, Silicon Valley Bank.
Will Elysium Health IPO soon?
No public IPO plans have been announced for Elysium Health.
How can I track Elysium Health secondary market activity?
Caplight tracks bids, offers, and trades in Elysium Health's shares on secondary markets.